FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to antibodies that specifically bind to hepcidin, which can be used in medicine. Monoclonal antibodies against the peptide of the N-terminal portion of hepcidin are obtained, which are used in the composition and used to treat diseases associated with elevated hepcidin levels or iron homeostasis disorders.
EFFECT: invention makes it possible to obtain therapeutically useful anti-hepcidin antibodies, having a high specificity and a low dissociation constant as compared to the analogues available in the current art.
27 cl, 32 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIKINE ANTIBODIES BINDING TO SEVERAL CC-CHEMOKINES | 2010 |
|
RU2574786C2 |
| HUMAN ONCOSTATIN M ANTIBODIES AND METHODS OF USE THEREOF | 2011 |
|
RU2600444C2 |
| THERAPEUTIC ANTIBODIES BINDING TO LEWIS B AND LEWIS Y BIANTENNA ANTIGENS | 2019 |
|
RU2803097C2 |
| ANTIBODIES FOR SPECIFIC BINDING OF STAPHYLOCOCCUS AUREUS ALPHA-TOXIN AND METHODS OF APPLICATION | 2012 |
|
RU2620065C2 |
| MOLECULES WHICH BIND TO PSL PSEUDOMONAS, AND METHODS FOR USE THEREOF | 2012 |
|
RU2708977C2 |
| METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES | 2014 |
|
RU2671481C2 |
| ANTIBODIES AGAINST G-CSFR AND USE THEREOF | 2012 |
|
RU2605595C2 |
| CONSTRUCTED ANTI-TSLP ANTIBODY | 2010 |
|
RU2575039C2 |
| HUMAN ANTIBODIES TO CLOSTRIDIUM DIFFICILE TOXINS | 2013 |
|
RU2628305C2 |
| METHODS FOR TREATMENT OF DISEASE, USING BONE MORPHOGENETIC PROTEIN 6 (BMP6) INHIBITORS | 2017 |
|
RU2790023C2 |
